Building a For-Profit Company with a Foundation of Empathy and Humanity - Harvard i-lab 2014

 

How do you design organizing principles that endure as an organization scales ? How do you seek out partners and employees that share your notions of purpose and can relate it to building a better product or service ? How do you stay plugged in to the human needs of the end user in the face of pressures to expand your efforts ?

In this fireside chat, PillPack CEO TJ Parker talks with Almighty CSO Ian Fitzpatrick about the ways in which his online pharmacy has evolved to build both a product and service experience rooted in an understanding of basic human needs, and the ways in which the PillPack organization has been challenged to maintain this design ethos as it scales.

Positioning Your Brand Out Front - Adrian Gill - Desirability, Differentiation and Design - Harvard i-lab 2015

 

Adrian Gill, Brand Consultant and Mentor at the Harvard Innovation Lab, shares a pragmatic view on how founders can create and maintain a more sustainable brand advantage through focus on 3 simple things; Desirability, Differentiation and Design.

Content covered includes :
Case study examples including client work on the Barbados + Rihanna brand campaign.
Guidance on designers, logos and developing impactful creative with no money.
Ways to avoid the trap of relying too heavily on functionality of technology to create differentiation. Where the new is instantly visible, functionality alone is not a bankable advantage.
Critical thinking around defining Brand Identity and how to make your brand "hard to follow" for the competition.

Foundations of Financings and Capital Raising for Startups - Harvard i-lab 2015

 

Raising capital in this financing environment is a challenge. It is important that you understand your business, your market, and the financing ecosystem so you can make the right choices to see your business reach its full potential. This session will help you understand how to raise capital from third parties, including selecting the right investors to help you achieve your goals. WilmerHale Partner Ed Pease (of the firm’s emerging company practice), alongside WilmerHale associate Avery Reaves, will present with on early-stage financings and raising seed capital.

The presentation will cover key issues for startup companies when raising capital, including :
· How to prepare your company for the fundraising process,
· Understanding the different potential sources of capital, and
· Understanding the legal and regulatory implications of fundraising

Learn more about the Harvard Innovation Lab at : http://i-Lab.Harvard.edu/

Understanding Reimbursement for Health and Life Sciences Startups - Harvard i-lab 2015

 

Being able to answer, "Will my device get reimbursed ?" has become critical, even for early development stage life sciences companies. From early investment rounds, investors want assurance of a return on their investment, and while they may not expect start-up companies to have all the reimbursement answers, they do expect companies to have identified the correct reimbursement questions. Investors understand that potential provider customers- hospitals and physicians- want to know they can access technologies to advance health care for patients, bill and be paid for their services and preserve their bottom line. Patients play a critical role in decision-making as they weigh their out-of-pocket costs; they want to know if their insurance will cover and pay for treatments.

This presentation led by Jo Ellen Slurzberg (VP Global Health Policy, JR Associates) will focus on why it is important to create an implementable business strategy that highlights and incorporates obtaining reimbursement and/or defining the value proposition for a product so it can be successfully commercialized in the ever-changing healthcare environment.

The Power of Wearable Technology in Sports - Isaiah Kacyvenski - Harvard i-lab 2016

 

We welcome Isaiah Kacyvenski, former 8-year NFL veteran and Head of the Consumer Business and Chairman of the Sports Advisory Board at MC10, to the i-lab to discuss the opportunities new and emerging technology provide to the Innovate in Sports. Isaiah will be giving his perspective about how electronics and their interactions with the human body can change the way athletes prepare to perform as well as how fans consume sports content. In other words - how can we use technology to take the guesswork out of preparation and performance and create even more engaging, truly unique content ?

Learn more about the Harvard Innovation Lab at : http://i-Lab.Harvard.edu
And follow us on Twitter at : http://Twitter.com/InnovationLab

Biodiversité, Génétique & Société - Planète Conférences : UBS - Université de Bretagne-Sud 2016

 

Par Pierre-Henri GOUYON, Professeur au Muséum National d'Histoire Naturelle, à l'AgroParisTech, à l'ENS et à Sciences Po Institut de Systématique, Évolution, Biodiversité – MNHN-CNRS, UMR 7205, Département de Systématique et Évolution Adresse : MNHN, CP39, 12 rue Buffon 75005 Paris

La biodiversité est un fait d’observation banal mais, de la systématique du XVIIIème siècle à la génétique du XXème, son interprétation a connu des périodes très différentes. La théorie de l’évolution lancée par Darwin il y a 150 ans constitue la base de la biologie contemporaine. L’écologie et l’idée de biodiversité, mais surtout la génétique sont issues de cette théorie qui affirme l’unité du Vivant, qui permet d’agir sur lui, mais qui pose de nombreux problèmes à la société, a servi de fondement à des idéologies ignobles et est refusée par les extrémistes religieux. Quant à la description et la sauvegarde de la biodiversité, elles reposent souvent sur des idées simplistes et peu convaincantes. Où en est-on de la compréhension de cette diversité ? et de nos actions sur elle ? Les biotechnologies se développent à grande vitesse et de nombreux débats concernant les risques pris mais aussi les aspects éthiques ou économiques ont vu le jour. Face au débat sur les OGM par exemple, les scientifiques ont souvent considéré les critiques comme essentiellement obscurantistes. Qu’en est-il ? Pourquoi tant d’incompréhension ? Peut-on espérer l’avènement d’un véritable échange entre science, technique et société dans le champ de la biologie ?

A Guide to Brilliant Strategy - Raymond Levitt, Carl Spetzler - Stanford Online Webinar 2016

 

There is nothing more frustrating for a project manager than having to execute a dumb decision. For leadership, it's not being able to execute a smart one. Alignment of strategy and execution is imperative, and effective management of the connection between steps is vitally important for business success.

In this webinar, Raymond Levitt, Professor of Civil and Environmental Engineering at Stanford University, and Carl Spetzler, CEO at Strategic Decisions Group, provide a guide for choosing high-value strategies that can be implemented through an aligned strategic execution process.

Learn more about the Stanford Advanced Project Management Certificate Program : http://APM.Stanford.Edu

Learn more about the Stanford Strategic Decision and Risk Management : http://StrategicDecisions.Stanford.Edu